Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Today's Top SOA Links


Free Research Reports on CHTP, GRPN, JAG and ZLCS Issued by the Bedford Report
Note to Editors: The Following Is an Investment Opinion Being Issued by the EQUITY NEWS CIRCUIT

NEW YORK, NY -- (Marketwire) -- 11/26/12 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is currently seeking approval by the FDA for Northera, which helps prevent dizziness in people with central nervous system disorders. In February, a FDA advisory panel voted 7-4 in favor of approval.

Find out more about Chelsea Therapeutics including full access to the free equity report at: www.BedfordReport.com/CHTP

Groupon Inc. (NASDAQ: GRPN) shares of the discount e-commerce company have fallen over 80 percent year-to-date. The company has struggled internationally with a sales growth of just 3.1% year-over-year, after a 31% growth in the second quarter.

Find out more about Groupon including full access to the free equity report at: www.BedfordReport.com/GRPN

Jaguar Mining Inc. (NYSE: JAG) (TSX: JAG) shares of the junior gold miner have fallen nearly 90 percent year-to-date. The company has lowered their fiscal 2012 gold production guidance to 100,000 to 110,000 ounces.

Find out more about Jaguar Mining including full access to the free equity report at: www.BedfordReport.com/JAG

Zalicus Inc. (NASDAQ: ZLCS) shares of the biopharmaceutical company have fallen nearly 20 percent in the last month. Analysts' at both MLV Capital and Rodman & Renshaw have downgraded the company's rating.

Find out more about Zalicus including full access to the free equity report at: www.BedfordReport.com/ZLCS

Disclaimer: Equity News Circuit is not a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security. A third party, bedfordreport.com has paid Equity News Circuit four hundred and fifty dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release.

Contact Information:

Equity News Circuit
Email Contact

About Marketwired .
Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Web 2.0 Latest News
The release of Kibana 4.x has had an impact on monitoring and other related activities.  In this post we’re going to get specific and show you how to add Node.js monitoring to the Kibana 4 server app.  Why Node.js?  Because Kibana 4 now comes with a little Node.js server app that...
I recently saw an unusual post online that caught my eye. It was a standard weather radar picture from a Wisconsin TV Station (WFRV-TV Ch. 5). In the image you can see a large green area that normally denotes rain. What particularly caught my eye was that this image labeled the large g...
DoubleDown Interactive, a provider of online free-to-play casino games, needs to process huge amounts of streaming event data from their games and make that data rapidly available to data scientists and analysts. Hear how Amazon S3 and Snowflake’s Elastic Data Warehouse have made it po...
What winning sales organizations do to separate themselves from the competition by creating market advantage through improved user experiences and better information services. The next BriefingsDirect thought-leader interview focuses on what winning sales organizations do to separate...
I read an insightful article this morning from Bernard Golden on DZone discussing the DevOps conundrum facing many enterprises today – is it better to build your own DevOps tools or go commercial? For Golden, the question arose from his observations at a number of DevOps Days events h...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE